Cargando…
Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence
Rare germline pathogenic variants in cancer‐predisposing genes have a high impact and potential for clinical utility. In the last 30 years, based on evidence of cancer risk associated with germline pathogenic variants, several measures have been suggested for personalized medicine, including the dev...
Autores principales: | Usui, Yoshiaki, Momozawa, Yukihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551596/ https://www.ncbi.nlm.nih.gov/pubmed/37530079 http://dx.doi.org/10.1111/cas.15922 |
Ejemplares similares
-
Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk
por: Usui, Yoshiaki, et al.
Publicado: (2022) -
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
por: Momozawa, Yukihide, et al.
Publicado: (2019) -
Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
por: Mizukami, Keijiro, et al.
Publicado: (2020) -
Unique roles of rare variants in the genetics of complex diseases in humans
por: Momozawa, Yukihide, et al.
Publicado: (2020) -
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
por: Momozawa, Yukihide, et al.
Publicado: (2018)